BioXcel Therapeutics, Inc. (BTAI): Price and Financial Metrics

BioXcel Therapeutics, Inc. (BTAI)

Today's Latest Price: $6.16 USD

0.44 (-6.67%)

Updated Dec 9 6:55pm

Add BTAI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

BTAI Daily Price Range
BTAI 52-Week Price Range

BTAI Stock Price Chart More Charts

BTAI Price/Volume Stats

Current price $6.16
Prev. close $6.60
Day low $6.10
Day high $6.73
50-day MA $5.55
200-day MA $8.94
52-week high $12.00
52-week low $2.41
Volume 102,700
Avg. volume 77,011
Dividend yield N/A
Market Cap 111.10M

BioXcel Therapeutics, Inc. (BTAI) Company Bio

BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent designed for the treatment of prostate and pancreatic cancers. It is also developing BXCL502, a novel approach to the treatment of symptoms resulting from neurological disorders; and BXCL702, an immuno-oncology agent for hematological malignancies. The company was founded in 2017 and is based in Branford, Connecticut. BioXcel Therapeutics, Inc. is a subsidiary of BioXcel Corporation.

BTAI Latest News Stream

Event/Time News Detail
Loading, please wait...

BTAI Latest Social Stream

Loading social stream, please wait...

View Full BTAI Social Stream

BTAI Price Returns

1-mo 50.98%
3-mo -39.96%
6-mo -43.62%
1-year 32.19%
3-year N/A
5-year N/A
YTD 59.59%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4549 seconds.